ABELZETA Trademark

Trademark Overview

On Monday, July 24, 2023, a trademark application was filed for ABELZETA with the United States Patent and Trademark Office. The USPTO has given the ABELZETA trademark a serial number of 98977102. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Tuesday, November 25, 2025. This trademark is owned by CELLULAR BIOMEDICINE GROUP, INC.. The ABELZETA trademark is filed in the Education & Entertainment Services category with the following description:

Educational services, namely, the presentation of lectures and panel discussions in the field of medicine
abelzeta

General Information

Serial Number98977102
Word MarkABELZETA
Filing DateMonday, July 24, 2023
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateTuesday, November 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 7, 2024

Trademark Statements

Goods and ServicesEducational services, namely, the presentation of lectures and panel discussions in the field of medicine
Description of MarkThe mark consists of the stylized word "ABELZETA" where "ABEL" is dark grey in color and "ZETA" is maroon in color.
Indication of Colors claimedThe colors dark grey and maroon are claimed as a feature of the mark.

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, August 22, 2023
Primary Code041
First Use Anywhere DateWednesday, January 10, 2024
First Use In Commerce DateWednesday, January 10, 2024

Trademark Owner History

Party NameABELZETA INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressROCKVILLE, MD 20850
Party NameABELZETA INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressROCKVILLE, MD 20850
Party NameCELLULAR BIOMEDICINE GROUP, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressROCKVILLE, MD 20850

Trademark Events

Event DateEvent Description
Thursday, July 27, 2023NEW APPLICATION ENTERED
Tuesday, August 22, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 23, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, August 28, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, December 27, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, January 19, 2024ASSIGNED TO LIE
Friday, January 19, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, March 26, 2024ASSIGNED TO EXAMINER
Friday, March 29, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, March 29, 2024EXAMINERS AMENDMENT E-MAILED
Friday, March 29, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 29, 2024EXAMINER'S AMENDMENT ENTERED
Friday, March 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 15, 2024SOU TEAS EXTENSION RECEIVED
Monday, July 15, 2024SOU EXTENSION 1 FILED
Monday, July 15, 2024SOU EXTENSION 1 GRANTED
Monday, July 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 3, 2025TEAS STATEMENT OF USE RECEIVED
Monday, June 23, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 23, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 23, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 3, 2025TEAS REQUEST TO DIVIDE RECEIVED
Monday, November 24, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 24, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 3, 2025DIVISIONAL REQUEST RECEIVED
Tuesday, November 25, 2025DIVISIONAL PROCESSING COMPLETE
Tuesday, June 3, 2025USE AMENDMENT FILED
Tuesday, November 25, 2025STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

abelzeta discussions field medicine panel lectures services namely presentation educational